Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 21 March, 2013 and appeared in  Women's HealthIssue 669

Two Glucose Uptake Mechanisms Affected by Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) poses a double impact in glucose control in women with the highest level of insulin resistance....

Advertisement

A recent study, compared 28 healthy women with 28 with PCOS showing that women with PCOS had a decrease in both insulin and non-insulin glucose controlling mechanisms. PCOS participants with the most insulin resistance at the start of the trial had results that showed a decline in their ability to compensate with non-insulin glucose controlling mechanisms.

Dr. Ricardo Azziz, reproductive endocrinologist and PCOS expert at Georgia Regents University, states, "Women with PCOS who have the highest levels of insulin resistance, the greatest difficulty controlling their sugar and the highest risk for diabetes, appear to have a double defect in how glucose is controlled, which affects both the mechanisms that use insulin and those that do not." The study measured visceral and subcutaneous fat distribution, which predicted the degree of insulin and non-insulin glucose control, respectively.

"If the fat is not as sensitive to insulin, that obviously means blood sugar levels, and probably fat and cholesterol levels as well, increase and the pancreas responds by producing more insulin," Azziz said. "Fat abnormalities can have a tremendous impact on how we feel and how we function."

In the future, the researchers want to construct a study that includes understanding the molecular mechanisms involved in how PCOS affects glucose usage.

Journal of Clinical Endocrinology & Metabolism, 2013; DOI: 10.1210/jc.2012-2937 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 21 March, 2013 and appeared in  Women's HealthIssue 669

Past five issues: SGLT-2 Inhibitors Special Edition April 2014 | Diabetes Clinical Mastery Series Issue 184 | Issue 724 | Diabetes Clinical Mastery Series Issue 183 | Issue 723 |

2014 Most Popular Articles:

Patient Handout: 7 Tips to Drop Excess Pounds with Diabetes
Posted April 04, 2014
Who Qualifies for Statin Treatment under the New Guidelines?
Posted March 27, 2014
Vitamin D's Effect on the Progression of Pre-type 1 Diabetes
Posted March 14, 2014
Updated Bolus Calculators for Diabetes Management
Posted March 20, 2014
A1C Is a Predictor of Clinical Outcomes Following Noncardiac Surgery
Posted March 14, 2014
Surprising Trends in the Use of Antidiabetic Drugs
Posted March 27, 2014
Abdominal Fat Accumulation Prevented by Unsaturated Fat
Posted March 14, 2014
Evidence Shows Possible Benefit of Metformin and Glyburide Use in Pregnancy
Posted March 14, 2014
Agavins: A Potential Alternative to Artificial Sweeteners
Posted March 27, 2014
Statin Side-effects Questioned
Posted March 20, 2014

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
Advertisement

Cast Your Vote
Was the data release from CMS on Medicare payments a good idea?
CME/CE of the Week
Silvia Inzucchi, MD

Category: General Diabetes
Credits: .75
Search Articles On Diabetes In Control